Lung Transplant Safe, Effective for COVID-19-Related End-Stage Lung Disease
Researchers assessed the characteristics and outcomes of patients having lung transplantation for COVID-19-related end-stage lung disease.
Researchers assessed the characteristics and outcomes of patients having lung transplantation for COVID-19-related end-stage lung disease.
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, certain features of this season’s outbreak set it apart from those of previous years.
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
How often do survivors of severe COVID-19 pulmonary infection experience long-term exercise capacity limitation, and what factors are associated with this condition?
While a subset of people with cystic fibrosis may experience a more severe clinical course of COVID-19, they are not at an increased risk of contracting SARS-CoV-2 compared with the general population.